Company Cash Funds: Biofrontera Inc. (BFRI)

Graphic logo of Biofrontera Inc. (BFRI)

Biofrontera Inc. relies on stable demand for skin cancer therapy drugs driven by strict medical protocols. Supply reliability is guaranteed by a certified temperature regime, while costs are reduced through outsourced distribution management. The company's cash flow dynamics demonstrate resilience to payment disruptions, with the current figure standing at 0.00.

Biofrontera Inc. - BFRI Company Total Cash Amount (period 07/04/2022 - 11/21/2026)

Financial and market metric breakdowns for Biofrontera Inc. (BFRI)

- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
Comprehensive company analysis:Biofrontera Inc. BFRI
Signature product of Biofrontera Inc

Balance sheet liquidity determines a business's ability to meet its obligations without external support. This indicator measures the volume of available cash, allowing for an assessment of cash gap risks and financial autonomy. For Biofrontera Inc. (BFRI), this reserve is critically important when scaling the distribution of drugs across US clinics. A sufficient capital cushion confirms the operational resilience of management. The dynamics of these resources are clearly demonstrated by the organization's cash balances.